SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will participate on a panel titled "Beyond Emerging Managers: Becoming an Established Manager" at the Emerging Managers 2009 Conference in Miami, FL
News | 04. 28. 2009
